EXHIBIT 1 AGREEMENT REGARDING JOINT FILING UNDER UNDER RULE 13D-1(K) OF THE EXCHANGE ACT In accordance with Rule 13d-1(k) under the Securities Exchange Act of 1934, as amended, each of the undersigned agrees to the filing on behalf of each of a...Agreement Regarding Joint • December 19th, 2005 • Enerteck Corp • Miscellaneous chemical products
In accordance with Rule 13d-1(k) under the Securities Exchange Act of 1934, as amended, each of the undersigned agrees to the filing on behalf of each of a Statement on Schedule 13D, and all amendments thereto, with respect to the shares of common stock, $.001 par value, of Enerteck Corporation.
AGREEMENT REGARDING JOINT FILING OF STATEMENTS ON SCHEDULE 13DAgreement Regarding Joint • August 19th, 2003 • Mellon HBV Master Rediscovered Opportunities Fund Lp • Services-prepackaged software
This Agreement Regarding Joint Filing of Statements on Schedule 13D dated as of August 19, 2003 (the “Agreement”) will confirm the agreement by and between the undersigned that the Statement on Schedule 13D filed on or about this date and any further amendments thereto with respect to the beneficial ownership by the undersigned of the shares of Common Stock of Peregrine Systems, Inc., a Delaware corporation, is being filed on behalf of each of the undersigned in accordance with Rule 13d-1(k)(1) promulgated under the Securities Exchange Act of 1934, as amended.
AGREEMENT REGARDING JOINT FILING OF STATEMENTS ON SCHEDULE 13DAgreement Regarding Joint • August 21st, 2003 • Mw Post Advisory Group LLC • Services-prepackaged software
This Agreement Regarding Joint Filing of Statements on Schedule 13D dated as of August 21, 2003 (the “Agreement”) will confirm the agreement by and between the undersigned that the Statement on Schedule 13D filed on or about this date and any further amendments thereto with respect to the beneficial ownership by the undersigned of the shares of Common Stock of Peregrine Systems, Inc., a Delaware corporation, is being filed on behalf of each of the undersigned in accordance with Rule 13d-1(k)(1) promulgated under the Securities Exchange Act of 1934, as amended.
AGREEMENT REGARDING JOINT FILING OF SCHEDULE 13GAgreement Regarding Joint • February 13th, 2020 • New Leaf Biopharma Opportunities II, L.P. • Pharmaceutical preparations
Pursuant to Rule 13d-1(k)(1) under the Securities Exchange Act of 1934, the undersigned hereby agree that only one statement containing the information required by Schedule 13G need be filed with respect to the ownership by each of the undersigned of shares of Common Stock of Aravive, Inc.
AGREEMENT REGARDING JOINT FILING OF SCHEDULE 13GAgreement Regarding Joint • November 6th, 2018 • New Leaf Biopharma Opportunities II, L.P. • Biological products, (no disgnostic substances)
Pursuant to Rule 13d-1(k)(1) under the Securities Exchange Act of 1934, the undersigned hereby agree that only one statement containing the information required by Schedule 13G need be filed with respect to the ownership by each of the undersigned of shares of Common Stock of Proteon Therapeutics, Inc.
AGREEMENT REGARDING JOINT FILING OF SCHEDULE 13DAgreement Regarding Joint • February 18th, 2004 • Blue Rhino Corp • Retail-retail stores, nec
The undersigned agree that this Amendment No. 1 to Statement on Schedule 13D to which this Agreement is attached is filed on behalf of each one of them pursuant to Rule 13d-1(k)(1)(iii). This Agreement may be executed in any number of counterparts, each of which shall be deemed to be an original and all of which shall together constitute one instrument.
AGREEMENT REGARDING JOINT FILING OF SCHEDULE 13GAgreement Regarding Joint • July 24th, 2018 • New Leaf Biopharma Opportunities II, L.P. • Pharmaceutical preparations
Pursuant to Rule 13d-1(k)(1) under the Securities Exchange Act of 1934, the undersigned hereby agree that only one statement containing the information required by Schedule 13G need be filed with respect to the ownership by each of the undersigned of shares of Common Stock of Versartis, Inc.
AGREEMENT REGARDING JOINT FILING OF SCHEDULE 13GAgreement Regarding Joint • February 21st, 2019 • New Leaf Ventures III, L.P. • Biological products, (no disgnostic substances)
Pursuant to Rule 13d-1(k)(1) under the Securities Exchange Act of 1934, the undersigned hereby agree that only one statement containing the information required by Schedule 13G need be filed with respect to the ownership by each of the undersigned of securities of the Issuer.
AGREEMENT REGARDING JOINT USE OF POLES BETWEENAgreement Regarding Joint • July 24th, 2020 • Florida
THIS AGREEMENT, effective this day of , 2020, is made by and between CITY OF LAKE WORTH BEACH, FLORIDA, which owns and operates a municipal electric utility (hereinafter referred to as the "CITY") and BellSouth Telecommunications, LLC, d/b/a AT&T Florida (hereinafter referred to as "AT&T").
AGREEMENT REGARDING JOINT FILING OF SCHEDULE 13GAgreement Regarding Joint • February 13th, 2020 • New Leaf Ventures II, L.P. • Surgical & medical instruments & apparatus
The undersigned, being duly authorized thereunto, hereby execute this agreement as an exhibit to this Schedule 13G to evidence the agreement of the below-named parties, in accordance with the rules promulgated pursuant to the Securities Exchange Act of 1934, to file this Schedule jointly on behalf of each such party.
AGREEMENT REGARDING JOINT FILING OF SCHEDULE 13GAgreement Regarding Joint • November 27th, 2019 • Osage University Partners III, LP • Pharmaceutical preparations
Pursuant to Rule 13d-1(k)(1) under the Securities Exchange Act of 1934, the undersigned hereby agree that only one statement containing the information required by Schedule 13G need be filed with respect to the ownership by each of the undersigned of securities of the Issuer.
AGREEMENT REGARDING JOINT FILING OF SCHEDULE 13GAgreement Regarding Joint • February 13th, 2020 • New Leaf Ventures II, L.P. • Pharmaceutical preparations
The undersigned, being duly authorized thereunto, hereby execute this agreement as an exhibit to this Schedule 13G to evidence the agreement of the below-named parties, in accordance with the rules promulgated pursuant to the Securities Exchange Act of 1934, to file this Schedule jointly on behalf of each such party.
AGREEMENT REGARDING JOINT FILING OF SCHEDULE 13GAgreement Regarding Joint • February 11th, 2021 • New Leaf Ventures III, L.P. • Biological products, (no disgnostic substances)
Pursuant to Rule 13d-1(k)(1) under the Securities Exchange Act of 1934, the undersigned hereby agree that only one statement containing the information required by Schedule 13G need be filed with respect to the ownership by each of the undersigned of shares of Common Stock of Passage Bio, Inc.
EXHIBIT A AGREEMENT REGARDING JOINT FILING -------------------------------- The undersigned, Clarence W. Schawk, David A. Schawk, Cathy Ann Schawk, A. Alex Sarkisian, Marilyn G. Schawk and Schawk 2005 Three Year GRAT, a grantor retained annuity trust,...Agreement Regarding Joint • May 23rd, 2005 • Schawk 2005 Three Year GRAT • Service industries for the printing trade
The undersigned, Clarence W. Schawk, David A. Schawk, Cathy Ann Schawk, A. Alex Sarkisian, Marilyn G. Schawk and Schawk 2005 Three Year GRAT, a grantor retained annuity trust, hereby agree and acknowledge that the statement containing the information required by Schedule 13D, to which this Agreement is attached as an exhibit, is filed on behalf of each of them. The undersigned further agree that any amendments or supplements thereto shall also be filed on behalf of each of them.
AGREEMENT REGARDING JOINT FILING OF SCHEDULE 13GAgreement Regarding Joint • February 13th, 2019 • New Leaf Ventures II, L.P. • Pharmaceutical preparations
Pursuant to Rule 13d-1(k)(1) under the Securities Exchange Act of 1934, the undersigned hereby agree that only one statement containing the information required by Schedule 13G need be filed with respect to the ownership by each of the undersigned of shares of Common Stock of Principia Biopharma Inc.
AGREEMENT REGARDING JOINT FILING OF SCHEDULE 13GAgreement Regarding Joint • December 4th, 2020 • Osage University Partners III, LP • Pharmaceutical preparations
Pursuant to Rule 13d-1(k)(1) under the Securities Exchange Act of 1934, the undersigned hereby agree that only one statement containing the information required by Schedule 13G need be filed with respect to the ownership by each of the undersigned of securities of the Issuer.
AGREEMENT REGARDING JOINT FILING OF STATEMENTS ON SCHEDULE 13DAgreement Regarding Joint • August 19th, 2003 • Peregrine Systems Inc • Services-prepackaged software
This Agreement Regarding Joint Filing of Statements on Schedule 13D dated as of August 18, 2003 (the “Agreement”) will confirm the agreement by and between the undersigned that the Statement on Schedule 13D filed on or about this date and any further amendments thereto with respect to the beneficial ownership by the undersigned of the shares of Common Stock of Peregrine Systems, Inc., a Delaware corporation, is being filed on behalf of each of the undersigned in accordance with Rule 13d-1(k)(1) promulgated under the Securities Exchange Act of 1934, as amended.
AGREEMENT REGARDING JOINT FILING OF SCHEDULE 13GAgreement Regarding Joint • February 13th, 2019 • New Leaf Biopharma Opportunities II, L.P. • Pharmaceutical preparations
Pursuant to Rule 13d-1(k)(1) under the Securities Exchange Act of 1934, the undersigned hereby agree that only one statement containing the information required by Schedule 13G need be filed with respect to the ownership by each of the undersigned of shares of Common Stock of Aravive, Inc.
EXHIBIT 1 AGREEMENT REGARDING JOINT FILING The undersigned, John C. Lorentzen and Penney Fillmer, agree that this Fourth Amendment to Schedule 13D, dated as of January 8, 2001 with respect to Broadview Media, Inc. (f/k/a Northwest Teleproductions,...Agreement Regarding Joint • January 9th, 2001 • Lorentzen John C • Services-motion picture & video tape production
The undersigned, John C. Lorentzen and Penney Fillmer, agree that this Fourth Amendment to Schedule 13D, dated as of January 8, 2001 with respect to Broadview Media, Inc. (f/k/a Northwest Teleproductions, Inc.) is being filed on behalf of each of them individually.
AGREEMENT REGARDING JOINT FILING OF STATEMENT ON SCHEDULE 13D OR 13GAgreement Regarding Joint • April 21st, 2003 • Weber Eugene M • Services-prepackaged software
The undersigned agree to file jointly with the Securities and Exchange Commission (the “SEC”) any and all statements on Schedule 13D or Schedule 13G (and any amendments or supplements thereto) required under Section 13(d) of the Securities Exchange Act of 1934, as amended, in connection with purchases by the undersigned of common stock of AXS-One, Inc. For that purpose, the undersigned hereby constitute and appoint London Merchant Securities PLC, a public limited company organized under the laws of England and Wales, as their true and lawful agent and attorney-in-fact, with full power and authority for and on behalf of the undersigned to prepare or cause to be prepared, sign, file with the SEC and furnish to any other person all certificates, instruments, agreements and documents necessary to comply with Section 13(d) and Section 16(a) of the Securities Exchange Act of 1934, as amended, in connection with said purchases, and to do and perform every act necessary and proper to be done i
AGREEMENT REGARDING JOINT FILING OF SCHEDULE 13GAgreement Regarding Joint • February 3rd, 2021 • Lundbeckfond Invest a/S • Pharmaceutical preparations
Pursuant to Rule 13d-1(k)(1) under the Securities Exchange Act of 1934, the undersigned hereby agree that only one statement containing the information required by Schedule 13G need be filed with respect to the ownership by each of the undersigned of shares of Common Stock of IMARA Inc.
AGREEMENT REGARDING JOINT FILING OF SCHEDULE 13GAgreement Regarding Joint • February 10th, 2021 • New Leaf Biopharma Opportunities I, L.P. • Pharmaceutical preparations
Pursuant to Rule 13d-1(k)(1) under the Securities Exchange Act of 1934, the undersigned hereby agree that only one statement containing the information required by Schedule 13G need be filed with respect to the ownership by each of the undersigned of Shares of Addex Therapeutics Ltd.
EXHIBIT 1 AGREEMENT REGARDING JOINT FILING The undersigned, John C. Lorentzen and Penney Fillmer, agree that this First Amendment to Schedule 13D, dated as of August 24, 1998 with respect to Northwest Teleproductions, Inc. is being filed on behalf of...Agreement Regarding Joint • August 26th, 1998 • Lorentzen John C • Services-motion picture & video tape production
The undersigned, John C. Lorentzen and Penney Fillmer, agree that this First Amendment to Schedule 13D, dated as of August 24, 1998 with respect to Northwest Teleproductions, Inc. is being filed on behalf of each of them individually.
AGREEMENT REGARDING JOINT FILING OF STATEMENT ON SCHEDULE 13D OR 13GAgreement Regarding Joint • April 21st, 2003 • Weber Eugene M • Photographic equipment & supplies
The undersigned agree to file jointly with the Securities and Exchange Commission (the “SEC”) any and all statements on Schedule 13D or Schedule 13G (and any amendments or supplements thereto) required under Section 13(d) of the Securities Exchange Act of 1934, as amended, in connection with purchases by the undersigned of common stock of Chyron Corporation. For that purpose, the undersigned hereby constitute and appoint London Merchant Securities PLC, a public limited company organized under the laws of England and Wales, as their true and lawful agent and attorney-in-fact, with full power and authority for and on behalf of the undersigned to prepare or cause to be prepared, sign, file with the SEC and furnish to any other person all certificates, instruments, agreements and documents necessary to comply with Section 13(d) and Section 16(a) of the Securities Exchange Act of 1934, as amended, in connection with said purchases, and to do and perform every act necessary and proper to be
AGREEMENT REGARDING JOINT FILING OF SCHEDULE 13GAgreement Regarding Joint • February 13th, 2020 • New Leaf Ventures III, L.P. • Biological products, (no disgnostic substances)
Pursuant to Rule 13d-1(k)(1) under the Securities Exchange Act of 1934, the undersigned hereby agree that only one statement containing the information required by Schedule 13G need be filed with respect to the ownership by each of the undersigned of securities of the Issuer.
AGREEMENT REGARDING JOINT FILING OF STATEMENT ON SCHEDULE 13D OR 13GAgreement Regarding Joint • January 9th, 2012 • Chesapeake Energy Corp • Crude petroleum & natural gas
The undersigned agree to file jointly with the Securities and Exchange Commission any and all statements on Schedule 13D or Schedule 13G (and any amendments or supplements thereto) required under Section 13(d) of the Securities Exchange Act of 1934, as amended, in connection with purchases by the undersigned of the common units representing limited partner interests in Chesapeake Midstream Partners, L.P.
EXHIBIT 99.1 AGREEMENT REGARDING JOINT FILING -------------------------------- The undersigned, Henderson Group plc, Henderson Global Investors (Holdings) plc and Henderson Global Investors Limited, hereby agree and acknowledge that the statement...Agreement Regarding Joint • June 2nd, 2005 • Henderson Group PLC • Electronic computers
The undersigned, Henderson Group plc, Henderson Global Investors (Holdings) plc and Henderson Global Investors Limited, hereby agree and acknowledge that the statement containing the information required by Schedule 13G, to which this Agreement is attached as an exhibit, is filed on behalf of each of them. The undersigned further agree that any amendments or supplements thereto shall also be filed on behalf of each of them.
AGREEMENT REGARDING JOINT FILING OF SCHEDULE 13GAgreement Regarding Joint • February 13th, 2020 • New Leaf Biopharma Opportunities I, L.P. • Pharmaceutical preparations
Pursuant to Rule 13d-1(k)(1) under the Securities Exchange Act of 1934, the undersigned hereby agree that only one statement containing the information required by Schedule 13G need be filed with respect to the ownership by each of the undersigned of shares of Common Stock of Sierra Oncology, Inc.
AGREEMENT REGARDING JOINT FILING OF SCHEDULE 13GAgreement Regarding Joint • February 13th, 2019 • New Leaf Ventures II, L.P. • Surgical & medical instruments & apparatus
Pursuant to Rule 13d-1(k)(1) under the Securities Exchange Act of 1934, the undersigned hereby agree that only one statement containing the information required by Schedule 13G need be filed with respect to the ownership by each of the undersigned of shares of Common Stock of Neuronetics, Inc.
AGREEMENT REGARDING JOINT FILING OF SCHEDULE 13GAgreement Regarding Joint • February 10th, 2021 • New Leaf Ventures II, L.P. • Surgical & medical instruments & apparatus
The undersigned, being duly authorized thereunto, hereby execute this agreement as an exhibit to this Schedule 13G to evidence the agreement of the below-named parties, in accordance with the rules promulgated pursuant to the Securities Exchange Act of 1934, to file this Schedule jointly on behalf of each such party.
AGREEMENT REGARDING JOINT FILING OF SCHEDULE 13GAgreement Regarding Joint • February 13th, 2019 • New Leaf Ventures III, L.P. • Pharmaceutical preparations
Pursuant to Rule 13d-1(k)(1) under the Securities Exchange Act of 1934, the undersigned hereby agree that only one statement containing the information required by Schedule 13G need be filed with respect to the ownership by each of the undersigned of shares of Common Stock of Unum Therapeutics Inc.
AGREEMENT REGARDING JOINT FILING OF SCHEDULE 13GAgreement Regarding Joint • February 13th, 2019 • New Leaf Biopharma Opportunities I, L.P. • Pharmaceutical preparations
Pursuant to Rule 13d-1(k)(1) under the Securities Exchange Act of 1934, the undersigned hereby agree that only one statement containing the information required by Schedule 13G need be filed with respect to the ownership by each of the undersigned of shares of Common Stock of Sierra Oncology, Inc.
